Contribution of alpha-synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI. Abu-Rumeileh S, Arajyan G, Reiman EM, Otto M, et al. Alzheimers Dement 2024;20:7411-7419.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abu-Rumeileh S, Arajyan G, Reiman EM, Otto M, et al. Contribution of alpha-synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI. Alzheimers Dement 2024;20:7411-7419.
PMID: 39177111